Syuto T - Search Results

1

Daily versus intermittent application of high-concentration tacalcitol ointment in combination with low-dose cyclosporin for psoriasis vulgaris.

Abe M, Syuto T, Hasegawa M, Sogabe Y, Yokoyama Y, Ishikawa O. Abe M, et al. Among authors: syuto t. J Dermatol. 2006 Feb;33(2):108-11. doi: 10.1111/j.1346-8138.2006.00022.x. J Dermatol. 2006. PMID: 16556277 Clinical Trial.

2

Clinical usefulness and patient satisfaction for treatment with low-dose cyclosporin administration in patients with moderate psoriasis vulgaris.

Abe M, Ishibuchi H, Syuto T, Sogabe Y, Yokoyama Y, Ishikawa O. Abe M, et al. Among authors: syuto t. J Dermatol. 2007 May;34(5):290-3. doi: 10.1111/j.1346-8138.2007.00275.x. J Dermatol. 2007. PMID: 17408436 Clinical Trial.

3

Successful treatment with cyclosporin administration for persistent benign migratory glossitis.

Abe M, Sogabe Y, Syuto T, Ishibuchi H, Yokoyama Y, Ishikawa O. Abe M, et al. Among authors: syuto t. J Dermatol. 2007 May;34(5):340-3. doi: 10.1111/j.1346-8138.2007.00284.x. J Dermatol. 2007. PMID: 17408445

4

Efficacy of high-concentration tacalcitol ointment in psoriasis vulgaris after changing from other high-concentration vitamin D3 ointments.

Syuto T, Ishibuchi H, Sogabe Y, Yokoyama Y, Ishikawa O. Syuto T, et al. Dermatol Online J. 2008 Feb 28;14(2):2. Dermatol Online J. 2008. PMID: 18700105 Clinical Trial.

5

Transitory pigmented purpuric dermatoses in a young Japanese female.

Abe M, Syuto T, Ishibuchi H, Yokoyama Y, Ishikawa O. Abe M, et al. Among authors: syuto t. J Dermatol. 2008 Aug;35(8):525-8. doi: 10.1111/j.1346-8138.2008.00514.x. J Dermatol. 2008. PMID: 18789073

6

Clinical usefulness of a supplementary cyclosporin administration with a topical application of maxacalcitol ointment for patients with moderate psoriasis vulgaris.

Abe M, Syuto T, Hasegawa M, Yokoyama Y, Ishikawa O. Abe M, et al. Among authors: syuto t. J Dermatol. 2009 Apr;36(4):197-201. doi: 10.1111/j.1346-8138.2009.00623.x. J Dermatol. 2009. PMID: 19348657

7

Successful treatment of psoriatic nails with low-dose cyclosporine administration.

Syuto T, Abe M, Ishibuchi H, Ishikawa O. Syuto T, et al. Eur J Dermatol. 2007 May-Jun;17(3):248-9. doi: 10.1684/ejd.2007.0163. Epub 2007 May 4. Eur J Dermatol. 2007. PMID: 17478392 Clinical Trial. No abstract available.

8

Evidence that PI3K, Rac, Rho, and Rho kinase are involved in basic fibroblast growth factor-stimulated fibroblast-Collagen matrix contraction.

Abe M, Sogabe Y, Syuto T, Yokoyama Y, Ishikawa O. Abe M, et al. Among authors: syuto t. J Cell Biochem. 2007 Dec 1;102(5):1290-9. doi: 10.1002/jcb.21359. J Cell Biochem. 2007. PMID: 17497700

9

Interleukin-6 counteracts effects of cyclosporin A on extracellular matrix metabolism by human dermal fibroblasts.

Abe M, Yokoyama Y, Syuto T, Ishibuchi H, Ishikawa O. Abe M, et al. Among authors: syuto t. Cell Tissue Res. 2008 Aug;333(2):281-8. doi: 10.1007/s00441-008-0629-1. Epub 2008 Jun 14. Cell Tissue Res. 2008. PMID: 18553108

10

Improvement of quality of life and clinical usefulness of cyclosporin administration in patients with nail psoriasis.

Abe M, Syuto T, Yokoyama Y, Ishikawa O. Abe M, et al. Among authors: syuto t. J Dermatol. 2011 Sep;38(9):916-8. doi: 10.1111/j.1346-8138.2010.01104.x. Epub 2010 Nov 22. J Dermatol. 2011. PMID: 21352333 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters